Axsome Therapeutics Inc (NASDAQ:AXSM)
| 72.19 Delayed Data As of Nov 24 |  +1.37 / +1.93%Today’s Change | 33.45 Today|||52-Week Range 109.94 | -30.16% Year-to-Date |
Latest AXSM News | Press Releases
| 5 Under-the-Radar Tickers That Will Stomp the Market in 2021 Nov 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 70.92 |
| Today’s open | 71.73 |
| Day’s range | 69.50 - 73.17 |
| Volume | 251,937 |
| Average volume (3 months) | 360,706 |
| Market cap | $2.7B |
Data as of 3:59pm ET, 11/24/2020
Growth & Valuation
| Earnings growth (last year) | -74.42% |
| Earnings growth (this year) | -37.36% |
| Earnings growth (next 5 years) | -49.70% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 14.97 |
Competitors
| ---- | ||
| MCRBSeres Therapeutics I... | -3.40 | -9.98% |
| BLUEbluebird bio Inc | -0.09 | -0.21% |
| NKTRNektar Therapeutics | +0.16 | +0.97% |
Data as of 4:00pm ET, 11/24/2020
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | -$0.77 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$68.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
